Ensurge Micropower Asa · OSL:ENSU
Ensurge Micropower Asa — Q1 2026 Earnings Presentation
11 slides from Ensurge Micropower Asa's earnings presentation, May 2026
Slide 1: Powering what comes next
Powering what comes next The solid-state lithium microbattery platform for wearables, hearables, medical and industrial built on semiconductor principles focused on safety, form factor flexibility and superior energy density. Q1 2026 Investor Presentation May 2026
Slide 2: Forward-looking statement
Forward-looking statement. This . presentation includes “forward-looking” statements, including, without Readers and prospective investors of the Group’s shares are cautioned that limitation, projections and expectations regarding Ensurge and its Forward-looking Statements are not guarantees of futu
Slide 3: Q1 Report: On the Path to Commercialization
May 2026 Q1 Report: On the Path to Commercialization Q1 2026 Q2 Q3 Q4 ✓ Operational foundation, the prerequisite for Rest of 2026: Commercialization reliable delivery, sustained partner engagement and scalability ❑ Ship product with repeatable performance ✓ Record multi-layer product performance wit
Slide 4: Q1 Achievements
May 2026 Q1 Achievements Shift to product-led model already yielding positive results Commercial Product Team • Expanded pipeline with marquee companies including and • Material performance improvements toward Proof-of- • Team rebalance toward battery product expertise yielding beyond health, medica
Slide 5: Record multi-layer cycle life and capacity retention, improving rapidly
May 2026 Record multi-layer cycle life and capacity retention, improving rapidly • Industry benchmark for capacity retention is 80%; 70% represents Improved encapsulation + the accepted threshold for an emerging battery chemistry at this multilayer cell architecture stage of development. • POC targe
Slide 6: Corning Joint Development Agreement (JDA)
May 2026 Corning Joint Development Agreement (JDA) • Corning Ribbon Ceramic cathode successfully integrated with Ensurge's microbattery platform; strong initial single-layer results. • Encapsulation materials and process development actively underway, with dedicated resources from both organizations
Slide 7: Product Status
May 2026 Product Status New Product Introduction Accomplished Today’s Focus Discovery Engineering Innovation Proof of Concept Engineering Validation Design Validation Production Validation Mass Production Initial prototype testing Technical feasibility testing Final product testing Pilot production
Slide 8: Marquee engagements in sensors, hearables, pet care and medical
May 2026 Marquee engagements in sensors, hearables, pet care and medical. A C T I V E P IP E L IN E C ASE STUD Y Leads Qualified In Discussion Top-3 global • Over 125 leads, including • In discussions with more • Progressing development eight Fortune 500 companies than a dozen top-tier contracts wit
Slide 9: Q1 26 Financials
May 2026 Q1 26 Financials USDk Q1 25 Q4 25 Q1 26 • USD 0.15M revenue, primarily from strategic development and partnership activities Revenue 0 0 154 • –USD 3.5M in Q1 26 EBITDA less capitalized R&D (excl. Cost 1,441 3,818 4,082 0.4M restructuring expenses), vs. –USD 3.6M in Q1 25 and –USD 5.5M in Q
Slide 10: 2026: The Year of Commercialization
May 2026 2026: The Year of Commercialization Q1 Q2-Q4 2026 Platform Validation Commercial Validation Scalability Laid operational foundation for: • Platform performance validated • Customer demand translated into • Platform-level partnerships to unlock against defined product product-led roadmap sca
Slide 11: Powering what comes next.
Powering what comes next. A NE W C AT E GORY OF B AT T E RY For a new generation of devices.